从降低剂量到最大化对比度:深度学习能否放大对比剂对脑磁共振图像质量的影响?一项阅片者研究
本研究在250例多参数脑MRI中训练深度学习网络,以标准剂量T1为参考增强低剂量梯度回波T1图像,并由2名神经放射科医生以快速自旋回波T1为参考进行阅片。处理后图像的对比噪声比、病灶-脑比值和对比增强百分比均优于原始梯度回波和参考快速自旋回波序列,直径大于10 mm病灶的平均敏感度从88%提高到96%,假检出率无显著差异。
要点
- 深度学习处理后的梯度回波T1图像在对比噪声比、病灶-脑比值和对比增强百分比上均优于原始梯度回波和快速自旋回波T1序列。
- 处理后图像使大于10 mm病灶的平均敏感度从88%提高到96%,假检出率保持0.02/例不变。
- 全部病灶纳入时敏感度从59%提高到75%,但假检出率从0.05/例增至0.14/例(P=0.06),未达统计学显著。
核心结论
- 所提出的深度学习方法成功放大了对比剂注射对梯度回波T1图像质量、对比水平和病灶检出性能的有益效应,序列敏感度最多提高16%,而假检出率保持相似。
研究设计与样本
- 回顾性单中心研究,纳入2019年11月至2021年3月在Gustave Roussy癌症园区采集的250例多参数脑MRI,训练集107例(年龄55±14岁,58名女性),测试集79例(年龄59±14岁,41名女性)。
关键影像表现/征象
- 对于有强化病灶的病例,处理后图像的对比噪声比为44.5,优于原始梯度回波T1的9.1和参考快速自旋回波T1的16.8(P<0.001)。
- 病灶-脑比值为1.66,优于原始梯度回波T1的1.31和参考快速自旋回波T1的1.44(P<0.001)。
- 对比增强百分比为112.4%,优于原始梯度回波T1的85.6%和参考快速自旋回波T1的92.2%(P<0.001)。
- 两名阅片者均更偏好处理后T1的整体图像质量,平均评分3.4/4 vs 2.7/4(P<0.001)。
诊断标准与关键数值
- 以快速自旋回波T1序列为参考,直径大于10 mm病灶的平均敏感度:原始梯度回波T1为88%,处理后T1为96%(P=0.008)。
- 以快速自旋回波T1序列为参考,全部大于5 mm病灶的敏感度:原始梯度回波T1为70%,处理后T1为85%(P<0.001)。
- 以快速自旋回波T1序列为参考,全部病灶(不论大小)的敏感度:原始梯度回波T1为59%,处理后T1为75%(P<0.001)。
- 假检出率:大于10 mm病灶原始与处理后均为0.02/例(P>0.99);大于5 mm病灶原始0.04/例 vs 处理后0.06/例(P=0.48);全部病灶原始0.05/例 vs 处理后0.14/例(P=0.06)。
临床应用与阅片要点
- 深度学习增强处理可提高梯度回波T1序列对强化病灶的对比噪声比和病灶-脑比值,有助于提升阅片者对强化病灶的检出信心。
- 处理后图像在大于10 mm和大于5 mm病灶中提高敏感度而假检出率无显著差异,但全部病灶纳入时假检出率有升高趋势(0.05 vs 0.14/例,P=0.06)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aim of this study was to evaluate a deep learning method designed to increase the contrast-to-noise ratio in contrast-enhanced gradient echo T1-weighted brain magnetic resonance imaging (MRI) acquisitions. The processed images are quantitatively evaluated in terms of lesion detection performance.
MATERIALS AND METHODS: A total of 250 multiparametric brain MRIs, acquired between November 2019 and March 2021 at Gustave Roussy Cancer Campus (Villejuif, France), were considered for inclusion in this retrospective monocentric study. Independent training (107 cases; age, 55 ± 14 years; 58 women) and test (79 cases; age, 59 ± 14 years; 41 women) samples were defined. Patients had glioma, brain metastasis, meningioma, or no enhancing lesion. Gradient echo and turbo spin echo with variable flip angles postcontrast T1 sequences were acquired in all cases. For the cases that formed the training sample, "low-dose" postcontrast gradient echo T1 images using 0.025 mmol/kg injections of contrast agent were also acquired. A deep neural network was trained to synthetically enhance the low-dose T1 acquisitions, taking standard-dose T1 MRI as reference. Once trained, the contrast enhancement network was used to process the test gradient echo T1 images. A read was then performed by 2 experienced neuroradiologists to evaluate the original and processed T1 MRI sequences in terms of contrast enhancement and lesion detection performance, taking the turbo spin echo sequences as reference.
RESULTS: The processed images were superior to the original gradient echo and reference turbo spin echo T1 sequences in terms of contrast-to-noise ratio (44.5 vs 9.1 and 16.8; P < 0.001), lesion-to-brain ratio (1.66 vs 1.31 and 1.44; P < 0.001), and contrast enhancement percentage (112.4% vs 85.6% and 92.2%; P < 0.001) for cases with enhancing lesions. The overall image quality of processed T1 was preferred by both readers (graded 3.4/4 on average vs 2.7/4; P < 0.001). Finally, the proposed processing improved the average sensitivity of gradient echo T1 MRI from 88% to 96% for lesions larger than 10 mm ( P = 0.008), whereas no difference was found in terms of the false detection rate (0.02 per case in both cases; P > 0.99). The same effect was observed when considering all lesions larger than 5 mm: sensitivity increased from 70% to 85% ( P < 0.001), whereas false detection rates remained similar (0.04 vs 0.06 per case; P = 0.48). With all lesions included regardless of their size, sensitivities were 59% and 75% for original and processed T1 images, respectively ( P < 0.001), and the corresponding false detection rates were 0.05 and 0.14 per case, respectively ( P = 0.06).
CONCLUSION: The proposed deep learning method successfully amplified the beneficial effects of contrast agent injection on gradient echo T1 image quality, contrast level, and lesion detection performance. In particular, the sensitivity of the MRI sequence was improved by up to 16%, whereas the false detection rate remained similar.
引用
- Bône, Ammari, Menu, et al. From Dose Reduction to Contrast Maximization: Can Deep Learning Amplify the Impact of Contrast Media on Brain Magnetic Resonance Image Quality? A Reader Study. Invest Radiol. 2022. PMID: 35446300. doi:10.1097/RLI.0000000000000867
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。